The workweek is ending, offering a chance to unwind and plan for the weekend. Whether you’re enjoying the outdoors, streaming content, or tackling your to-do list, take time to relax and stay safe.
FDA Proposes Removing 'Gender' References in Regulations
The U.S. Food and Drug Administration (FDA) has proposed a rule to remove references to “gender” from its regulations, citing a 2025 executive order from President Trump that emphasizes “biological sex” in federal policies. The FDA stated the proposal “does not impact industry practice” and “does not anticipate any measurable change in industry.” However, legal experts warn of potential broader impacts on drug testing and clinical trial representation, particularly for underrepresented gender minority groups.
Louisiana Challenges Abortion Pill Access via Telemedicine
Louisiana has urged the U.S. Supreme Court to block the prescription of abortion pills through telemedicine and their distribution by mail. The state, led by Republican Attorney General Liz Murrill, is challenging a 2023 federal rule issued during President Joe Biden’s administration that expanded access to the medication mifepristone. Murrill’s office argues that the rule has allowed medication abortions to increase despite Louisiana’s near-total ban on abortion. The state filed a motion asking the Supreme Court to deny emergency requests by two manufacturers to lift a lower court’s decision restricting access to the pill nationwide while the legal challenge proceeds.
Related articles
FDA Rejects Melanoma Drug RP1 Amid Leadership Controversy Under Makary
The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw th...
Justice Department Accuses Yale and UCLA Medical Schools of Racial Discrimination in Admissions
The Justice Department sent a letter to Yale School of Medicine on Thursday, alleging it was illegally discriminating against applicants who are not B...
PSA Screening Significantly Lowers Prostate Cancer Death Risk, Cochrane Review Confirms
Prostate-specific antigen (PSA) blood testing is likely to reduce the risk of death from prostate cancer, found a new review published on Thursday by...
Supreme Court Blocks Restrictions on Abortion Pill Mifepristone, Ensuring Continued Access
WASHINGTON — The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restri...
Dr. Makary's Exit and the Future of Cassidy's Senate Seat: Key Health Policy Shifts
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he...
CDC to Relocate 160+ Monkeys to Sanctuary in Bid to End Animal Testing
As part of efforts to phase out the use of monkeys in research, the Centers for Disease Control and Prevention intends to transfer more than 160 macaq...
Who Will Lead the FDA Next? The Search for a New Commissioner Heats Up
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...
BeOne Secures FDA Approval for Novel Lymphoma Cell Therapy, Advancing Autoimmune Treatment Pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Biotech’s cell therapy boo...